홈
overview
OVERVIEW
Mission of Cellivery is to commercialize life-saving therapeutics and cultivate revenue generating partnerships with companies in biotechnology and the pharmaceutical industry around world.
R&D Center
R&D CENTER
Intracellular Protein Therapy with TSDT
Protein transduction exploits the ability of specific basic-,amphipathic- and hydrophobic- cell penetrating peptide (CPP) sequences to enhance the uptake of proteins and other macromolecules by mammalian cells.
PIPELINE
PIPELINE
All of Cellivery starts from R&D.
Introducing Cellivery's pipeline.
-
TSDT Platform
Advanced Macromolecule Transduction Domain (aMTD)-enabled... more
-
iCP-SOCS3
Suppressor of cytokine signaling 3 (SOCS3) functions as a negative... more
-
iCP-Parkin
A BBB-Crossing Protein Savior For Damaged Neurons... more
-
CP-BMP2
No Carrier! Only Simple Injection For Bone Regeneration!... more
-
CP-ΔSOCS3
The abnormal control of leptin, an adipocyte-secreted hormone controll... more
-
iCP-Cre
Genetically engineered mouse models are useful tools for studying gene... more
-
iCP-RFs/Cas9
Terminally differentiated somatic cells can be reprogrammed to... more
-
CV-14
Ataxia is a neurodegenerative disease defined as an impaired voluntary coordination... more
-
iCP-NI
Sepsis is one of the 10 leading causes of death worldwide and widely... more
-
CV-16
Single-chain variable fragment (scFv) consists of the smallest functional antigen... more
PRESS RELEASE / IR
MEDIA
Cellivery
R&D introduction
Video
R&D is a starting point of drug development and commercialization and a locomotive in realizing continuous growth.
PARTNER
